首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Authors:Lorenza Rimassa  Tiziana Pressiani  Corrado Boni  Carlo Carnaghi  Elena Rota Caremoli  Stefano Fagiuoli  Paolo Foa  Stefania Salvagni  Enrico Cortesi  Maria Chiara Tronconi  Nicola Personeni  Silvia Bozzarelli  Maria Chiara Banzi  Silvia Fanello  Fabio Romano Lutman  Laura Giordano  Armando Santoro
Affiliation:1. aMedical Oncology and Hematology Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy;2. bMedical Oncology, Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia, Italy;3. cDepartment of Oncology and Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy;4. dDivision of Gastroenterology and Transplant Hepatology, Department of Medicine, Ospedali Riuniti di Bergamo, Bergamo, Italy;5. eDepartment of Oncology, San Paolo University Hospital, Milan, Italy;6. fOncology Division, Azienda Ospedaliero‐Universitaria, Parma, Italy;7. gDepartment of Radiology, Oncology and Human Pathology, Sapienza University of Rome, Roma, Italy;8. hDepartment of Radiology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy;9. iBiostatistics Unit, Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号